Harrow HROW
NASDAQ HROW
$40.95 -1.11 (-2.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026)

Harrow (HROW) posted quarterly Depreciation & Amortization (CF) of $455000.0 for Q1 2026, down 2.15% year-over-year from $465000.0 in Q1 2025, and down 1.94% quarter-over-quarter from $464000.0 in Q4 2025.

Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Harrow's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $455000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 2.15% year-over-year to $455000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 1.17% YoY), while the FY2025 annual figure was $1.9 million, up 3.51% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $455000.0, down from $464000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $497000.0 in Q3 2024, with the low at $247000.0 in Q3 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $435000.0 (2023), against an average of $425117.6.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) sank 38.1% in 2022, then surged 63.97% in 2023.
  • Harrow's Depreciation & Amortization (CF) stood at $387000.0 in 2022, then advanced by 12.4% to $435000.0 in 2023, then rose by 7.59% to $468000.0 in 2024, then declined by 0.85% to $464000.0 in 2025, then decreased by 1.94% to $455000.0 in 2026.
  • Business Quant data shows HROW's Depreciation & Amortization (CF) at $455000.0 in Q1 2026, $464000.0 in Q4 2025, and $490000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Harrow 1.53 Bn 1.45 Bn 50.36 Mn 460,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 460,000.00
Jun 30, 2026 460,000.00
Mar 31, 2026 455,000.00
Mar 31, 2026 455,000.00
Dec 31, 2025 464,000.00
Dec 31, 2025 464,000.00
Sep 30, 2025 490,000.00
Sep 30, 2025 490,000.00
Jun 30, 2025 496,000.00
Jun 30, 2025 496,000.00
Mar 31, 2025 465,000.00
Mar 31, 2025 465,000.00
Dec 31, 2024 468,000.00
Dec 31, 2024 468,000.00
Sep 30, 2024 497,000.00
Sep 30, 2024 497,000.00
Jun 30, 2024 453,000.00
Jun 30, 2024 453,000.00
Mar 31, 2024 432,000.00
Mar 31, 2024 432,000.00